LHP-588

N/A

Report date: 2023/11/17 15:57:37
NME

Base Information

Drug NameLHP-588
Drug Alias NameLHP-588COR-588
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptide hydrolase inhibitors
TargetsPeptide hydrolase
Therapy Area/IndicationsPorphyromonas infectionAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPorphyromonas infectionAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A